MedTrace Logo

Epiretinal Membrane and Cystoid Macular Oedema Post-cataract Surgery

NCT03965078 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 123

Last updated 2022-10-03

No results posted yet for this study

Summary

This study examines whether the presence of an epiretinal membrane affects the time to resolution, requirement for non-topical treatment, and outcome of pseudophakic cystoid macular oedema.

Conditions

  • Pseudophakic Cystoid Macular Oedema
  • Epiretinal Membrane

Interventions

DRUG

topical (eye drop) anti-inflammatories

Initial treatment with topical anti-inflammatory eye drops at the discretion of the reviewing clinician

Sponsors & Collaborators

  • Portsmouth Hospitals NHS Trust

    lead OTHER_GOV

Principal Investigators

  • Yit Fung Yang · Portsmouth Hospitals Trust

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-06-21
Primary Completion
2022-07-13
Completion
2022-07-15

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03965078 on ClinicalTrials.gov